These findings may indicate that during pulmonary fibrosis development, the Th2 CD4+ T cell population contributes to the increased expression of IL-31 in fibrotic lung lesions; within these lung lesions, IL-31 interacts with the unique receptor IL-31RA that is expressed in stromal cells. Here, IL31 is linked to pulmonary fibrosis.